Haleon (LON:HLN) Given New GBX 335 Price Target at JPMorgan Chase & Co.

Haleon (LON:HLN) had its price objective increased by JPMorgan Chase & Co. from GBX 315 to GBX 335 in a report released on Wednesday,London Stock Exchange reports. They currently have an underweight rating on the stock.

HLN has been the topic of several other reports. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a GBX 370 price target on shares of Haleon in a research report on Friday, October 31st. Berenberg Bank raised their target price on Haleon from GBX 507 to GBX 517 and gave the company a “buy” rating in a report on Wednesday, November 5th. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 440 price target on shares of Haleon in a research report on Monday, November 3rd. Finally, The Goldman Sachs Group reissued a “buy” rating and issued a GBX 440 price objective on shares of Haleon in a research report on Wednesday, September 10th. Three equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of GBX 420.40.

Haleon Stock Performance

LON:HLN opened at GBX 369 on Wednesday. The firm has a market capitalization of £32.86 billion, a PE ratio of 22.10, a PEG ratio of 1.49 and a beta of 0.19. Haleon has a 1 year low of GBX 325.10 and a 1 year high of GBX 419.50. The company has a current ratio of 0.84, a quick ratio of 0.93 and a debt-to-equity ratio of 53.36. The firm’s fifty day simple moving average is GBX 350.40 and its 200 day simple moving average is GBX 367.16.

About Haleon

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s product portfolio spans six major categories – Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other.